CN109260464A
|
|
The new application of anti-platelet thrombolysin
|
CN109464659A
|
|
Application of the anti-platelet thrombolysin in preparation treatment anaemia drug
|
CN109053479A
|
|
A kind of synthetic method of quaternary amine inner salt
|
CN108853061A
|
|
A kind of artificial synthesized Curosurf pharmaceutical composition and capsulae enterosolubilis and preparation method and the usage therewith
|
CN108785665A
|
|
A kind of medical composition and its use of snake venom blood coagulation enzyme
|
CN107383069A
|
|
Hydrochloric acid NM394 crystal and its production and use
|
CN107501298A
|
|
Hydrochloric acid NM394 crystal and its production and use
|
CN111849795A
|
|
Preparation method of heterodimer snake venom protein
|
CN111035754A
|
|
Application of antiplatelet thrombolysin in preparation of medicine for treating thrombotic thrombocytopenic purpura
|
CN104072637A
|
|
Preparation method for low-molecular-weight heparin calcium
|
CN104072638A
|
|
Preparation method of nadroparin calcium
|
CN103735495A
|
|
Ciclosporin eye gel and preparation method thereof
|
CN103263663A
|
|
Application of antiplatelet thrombolysin in preparation of medicament for treating von willebrand factor (VWF) defective thrombosis disease
|
CN103263662A
|
|
Application of antiplatelet thrombolysin in preparation of medicament for treating thrombosis disease under condition of low shear force
|
CN102895649A
|
|
Medicinal composition for treating liver injury and method for preparing medicinal composition for treating liver injury
|
CN102600146A
|
|
Lercanidipine hydrochloride and losartan potassium compound preparation and preparation method thereof
|
CN102614497A
|
|
Usage of human interferon in preparation of medicines for treatment or prevention of HPV (human paillomavirus) related diseases
|
CN102579453A
|
|
Compound preparation for treating gastric ulcer and preparation method of same
|
CN102798598A
|
|
Method for detecting enzymatic activity of phospholipid-depending factor X activator
|
CN102798632A
|
|
Method for detecting activity of batroxobin
|